Histological study of PIVKA-II expression in hepatocellular carcinoma and adenomatous hyperplasia

Pathology International

Volumn 51, Issue 12, 2001, Pages 916-922

  Upik, Anderiani Miskad ^a   Yano, Yoshihiko ^a   Nakaji, Miyuki ^a   Kishi, Shinji ^a   Itoh, Hiroshi ^a   Soo, Ryang Kim ^b   Ku, Yonson ^a   Kuroda, Yoshikazu ^a   Hayashi, Yoshitake ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOBE ASAHI HOSPITAL   (Japan)

Author keywords

Adenomatous hyperplasia; Hepatocellular carcinoma; Histology; Immunostain; PIVKA II; Tumor marker

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN; PROTEIN PIVKA 2; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOMA; ADULT; AGED; ARTICLE; CANCER CELL; CANCER GRADING; CONTROLLED STUDY; CYTOPLASM; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STAINING; TUMOR VOLUME;

ADENOMA; ADULT; AGED; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROTEIN PRECURSORS; PROTHROMBIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0035722291     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2001.01296.x     Document Type: Article

References (23)

1. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma
2. Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma
3. Des-gamma-carboxy prothrombin and proliferative activity of hepatocellular carcinoma
4. Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: A prospective analysis of 227 patients
5. Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein
6. The usefulness of determining Des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma
7. Usefulness of ED 036 kit for measuring serum PIVKA-II levels in small hepatocellular carcinoma
8. Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma
9. Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alfa-fetoprotein in hepatocellular carcinoma
10. Immunolocalisation of PIVKA-II in paraffin-embedded specimens of hepatocellular carcinoma
11. Primary carcinoma of the liver: A study of 100 cases among 48 900 necropsies
12. Early recognition of hepatocellular carcinoma
13. Primary liver cancer in Japan
14. Simultaneous measurements of alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma
15. Benign and malignant nodules in cirrhotic livers: Distinction based on blood supply
16. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity
17. Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma
18. Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes
19. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma
20. Serum des-gamma-carboxy prothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: Clinical significance in small hepatocellular carcinoma
21. Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma
22. Detection of PIVKA-II produced by human hepatoma cells in nude mice